21 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... inhibitors #EBM #trial #visualabstract ... #table #CVD #CKD
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
properties of approved SGLT2 ... Ertugliflozin #SGLT2 ... #Inhibitors #pharmacology ... #table
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Acetazolamide, others SGLT2 ... #Medications #Pharmacology ... #summary #table ... #nephrology
#visualabstract #sglt2i #nephrology
#visualabstract ... #sglt2i #nephrology
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
#CKD4 #Dosing #Pharmacology ... #VisualAbstract ... #Nephrology
Therapeutic Indications for the Anticonvulsant Agents

#Anticonvulsant #Antiseizure #Medications #Pharmacology #Table #Neurology #Epilepsy #Management
#Medications #Pharmacology ... #Table #Neurology
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Kayexelate #Comparison #Table ... #Pharmacology # ... #HyperKalemia #Nephrology
Conversion - Epoetin alfa (Procrit®) to Darbepoetin alfa (Aranesp™)

#Epoetin #Darbepoetin #Erythropoietin #Conversion #Table #ESAs #Procrit #Aranesp
Erythropoietin #Conversion #Table ... Procrit #Aranesp #Pharmacology ... #Hematology #Nephrology
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
Spironolactone MCW Nephrology ... #diuretics #pharmacology ... halflife #comparison #table
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
receptor agonist, SGLT2i ... #Medications #pharmacology ... #comparison #table